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Our plan is to therapeutically increase the levels of a natural antioxidant, catalase, in the cochlear and brain to reduce 
the oxidative stress. We have two problems to overcome - we have to target the catalase inside the cochlear and brain 
cells where it can most effectively combat oxidative stress, and we have to develop a delivery mechanism to cross the 
blood-brain barrier.
The Findings
Through in vitro experiments with two models, we demonstrated that targeted catalase provides protection for 
cochlear cells against oxidative stress, including compared to a non-targeted antioxidant which was unable to provide 
any protection.
We used tiny membrane structures, known as exosomes, to package the catalase. These exosomes are part of the 
body’s own transport mechanism for moving biomolecules between cells and have proved suitable here.
We were able to demonstrate production of this catalase in larger quantities necessary for future in vivo testing.
Finally, any new pharmaceutical must be demonstrated as safe overall before in vivo testing can take place. We chose 
to administer the catalase through the nose and we were able to show that it did cross the blood-brain barrier, without 
causing negative impacts on other organs in the body.
Key Points
A targeted catalase, packaged and 
delivered via exosomes intranasally, 
provides protection for cochlear cells 
against oxidative stress, the kind of 
stress that results from loud noise 
exposure. It is able to cross the blood-
brain barrier and does not result in 
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Background
Hearing loss is one of the most prevalent chronic health conditions 
worldwide and one of the fastest-growing conditions facing Canadians. 
Age-related hearing loss is common but another leading cause of 
hearing loss worldwide is excessive exposure to loud noise. This could 
be environmental (e.g. city noise), recreational (e.g. loud music) or 
workplace (e.g. industry or military) related noise.
Hearing loss has huge implications on our ability to communicate 
effectively, and there is clear evidence that it increases the risk for 
developing dementia, including Alzheimer’s disease, and accelerates 
age-related cognitive decline.
The Research
It is well known that noise exposure leads to oxidative stress in the 
sensory cells in the cochlea, as well as in the brain. Since oxidative stress 
appears to be a common factor in noise trauma, we really need a trusted 
pharmaceutical to take after noise exposure that could effectively reduce 
the oxidative stress in both the cochlea and the brain. Unfortunately, 
no such treatment exists. There have been attempts to flood the body 
with traditional antioxidants but without success. A new approach was 
warranted to address this unmet clinical need.
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Next Steps
Having established that targeted catalase can safely protect cochlear cells from oxidative stress, that we can package 
it and transport it through the blood-brain barrier and that we can produce it in large quantities, the next step is to 
test the level of protection in vivo against actual noise-induced cochlear damage, hearing loss and auditory processing 
deficits, as well as the cognitive impairment that persists post-noise exposure.
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